Group One Trading
TBPH icon

Group One Trading’s Theravance Biopharma TBPH Stock Holding History

Group One Trading’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-900
Closed -$13.1K – 9139
2025
Q3 		$13.1K Buy
900
+600
+200% +$7.58K ﹤0.01% 7002
2025
Q2 		$3.31K Buy
+300
New +$2.92K ﹤0.01% 7243
2025
Q1 		– Sell
-600
Closed -$5.65K – 8362
2024
Q4 		$5.65K Hold
600
– – ﹤0.01% 6370
2024
Q3 		$4.84K Buy
+600
New +$5.2K ﹤0.01% 5896
2024
Q2 		– Sell
-100
Closed -$897 – 7467
2024
Q1 		$897 Sell
100
-12,700
-99% -$118K ﹤0.01% 6655
2023
Q4 		$144K Buy
12,800
+10,700
+510% +$108K ﹤0.01% 4161
2023
Q3 		$18.1K Buy
2,100
+1,800
+600% +$17.4K ﹤0.01% 5951
2023
Q2 		$3.1K Sell
300
-9,900
-97% -$109K ﹤0.01% 6929
2023
Q1 		$111K Sell
10,200
-74,600
-88% -$789K ﹤0.01% 4224
2022
Q4 		$951K Buy
84,800
+64,400
+316% +$677K ﹤0.01% 2456
2022
Q3 		$207K Buy
20,400
+11,100
+119% +$104K ﹤0.01% 4114
2022
Q2 		$84K Buy
9,300
+7,800
+520% +$71.9K ﹤0.01% 5146
2022
Q1 		$14K Sell
1,500
-21,100
-93% -$207K ﹤0.01% 7009
2021
Q4 		$250K Sell
22,600
-82,600
-79% -$720K ﹤0.01% 4866
2021
Q3 		$778K Buy
+105,200
New +$1.18M ﹤0.01% 3690
2021
Q2 		– Sell
-1,100
Closed -$225K – 8571
2021
Q1 		$225K Sell
1,100
-2,800
-72% -$53.2K ﹤0.01% 4900
2020
Q4 		$69K Buy
+3,900
New +$70K ﹤0.01% 4805
2020
Q3 		– Sell
-200
Closed -$4K – 6541
2020
Q2 		$4K Sell
200
-7,200
-97% -$185K ﹤0.01% 5446
2020
Q1 		$171K Buy
7,400
+5,900
+393% +$148K ﹤0.01% 2883
2019
Q4 		$39K Sell
1,500
-1,000
-40% -$19.4K ﹤0.01% 4122
2019
Q3 		$49K Sell
2,500
-3,200
-56% -$64.7K ﹤0.01% 3978
2019
Q2 		$93K Buy
+5,700
New +$115K ﹤0.01% 3411
2018
Q4 		– Sell
-3,100
Closed -$101K – 5395
2018
Q3 		$101K Buy
+3,100
New +$84.5K ﹤0.01% 3530
2017
Q4 		– Sell
-5,300
Closed -$181K – 5214
2017
Q3 		$181K Buy
+5,300
New +$173K ﹤0.01% 2833
2017
Q1 		– Sell
-25,000
Closed -$797K – 4988
2016
Q4 		$797K Buy
25,000
+17,500
+233% +$543K 0.01% 1461
2016
Q3 		$272K Buy
+7,500
New +$209K ﹤0.01% 2260
2016
Q2 		– Sell
-10,200
Closed -$192K – 4939
2016
Q1 		$192K Buy
10,200
+9,200
+920% +$151K ﹤0.01% 2344
2015
Q4 		$16K Buy
1,000
+600
+150% +$9.52K ﹤0.01% 4014
2015
Q3 		$4K Buy
400
+200
+100% +$2.55K ﹤0.01% 4564
2015
Q2 		$3K Sell
200
-500
-71% -$7.75K ﹤0.01% 4619
2015
Q1 		$12K Buy
+700
New +$12.8K ﹤0.01% 4089

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Group One Trading's TBPH Position: Q1 2026 in Review

Group One Trading increased its Theravance Biopharma (TBPH) stake by 1,282% in Q1 2026, buying an estimated $215K and bringing the position to 13,125 shares worth $213K. The position accounts for ﹤0.01% of the portfolio, ranked #4059.

Group One Trading first reported a position in TBPH in Q2 2014 and has held it in 23 quarters since. The position peaked at $973K in Q2 2019. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Group One Trading held 13,125 shares of Theravance Biopharma worth $213K as of Q1 2026.
  • Group One Trading bought 12,175 Theravance Biopharma shares in Q1 2026, an estimated $215K.
  • Theravance Biopharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4059 holding.
  • Group One Trading first reported a position in Theravance Biopharma in Q2 2014 and has held it in 23 quarters since.
  • Group One Trading's Theravance Biopharma position peaked at $973K in Q2 2019.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.